10-Q: Actelis Networks Reports Q3 Loss Amid Revenue Decline, Nasdaq Delisting Concerns

Sentiment:

Quarterly Report


Actelis Networks reported a significant increase in net loss for Q3 2025 and the nine months ended September 30, 2025, driven by lower revenues and consistent operating expenses, while actively addressing Nasdaq listing compliance issues.

Capital raiseJuly 2025 Private Placement: Issued 1,626,019 shares and warrants for $1 million gross proceeds.September 2025 Warrant Inducement: Holder exercised 4,270,197 existing warrants for cash at a reduced price of $0.37/share, generating $1.6 million gross proceeds, in exchange for new warrants to purchase 6,405,296 shares.September 2025 PIPE (White Lion): Issued 871,766 shares and pre-funded warrants for 3,128,234 shares to White Lion for $850,000 gross proceeds.Equity Line of Credit (ELOC) Agreement with White Lion Capital, LLC: Effective October 1, 2025, provides the right to sell up to $30 million in common stock over a 36-month period.At the Market (ATM) Offering Agreement: Issued 3,051,195 shares for $2,637,000 gross proceeds during the nine months ended September 30, 2025.
Worse than expectedRevenues for the three months ended September 30, 2025, decreased by 74.6% compared to the prior year.Revenues for the nine months ended September 30, 2025, decreased by 65.6% compared to the prior year.Net comprehensive loss for the three months ended September 30, 2025, increased by 287.5% compared to the prior year.Net comprehensive loss for the nine months ended September 30, 2025, increased by 123.0% compared to the prior year.Operating loss for both the three and nine months ended September 30, 2025, significantly increased compared to the prior year.Net cash used in operating activities increased for the nine months ended September 30, 2025, indicating a greater burn rate from core operations.

Summary

  • Net loss for the three months ended September 30, 2025, increased to $1.98 million from $0.51 million in the prior year.
  • Net loss for the nine months ended September 30, 2025, increased to $5.74 million from $2.58 million in the prior year.
  • Revenues for the three months ended September 30, 2025, decreased significantly to $0.64 million from $2.54 million in the prior year.
  • Revenues for the nine months ended September 30, 2025, decreased to $2.31 million from $6.70 million in the prior year.
  • Operating loss for the three months ended September 30, 2025, was $1.93 million, up from $0.32 million in the prior year.
  • Operating loss for the nine months ended September 30, 2025, was $5.51 million, up from $2.12 million in the prior year.
  • Cash and cash equivalents stood at $1.45 million as of September 30, 2025, down from $1.97 million at December 31, 2024.
  • The company has an accumulated deficit of $50 million as of September 30, 2025.
  • Management has raised substantial doubt about the company's ability to continue as a going concern for at least one year.
  • The company is actively addressing Nasdaq listing compliance issues related to minimum shareholders' equity and minimum bid price, with a reverse stock split (1-for-10) approved by shareholders on November 7, 2025.
  • The company secured $1 million from a July 2025 private placement, $1.6 million from a September 2025 warrant inducement, and $0.85 million from a September 2025 PIPE transaction.
  • An Equity Line of Credit (ELOC) agreement with White Lion Capital, LLC, effective October 1, 2025, provides the right to sell up to $30 million in common stock over 36 months.

Sentiment

Score: 2

Explanation: The company faces severe financial challenges, including substantial revenue declines, increased losses, and a going concern warning. While it has successfully raised capital, these funds appear to be primarily for sustaining operations rather than driving profitable growth, and the company continues to struggle with Nasdaq listing requirements.

Positives

  • Net cash provided by financing activities significantly increased to $5.12 million for the nine months ended September 30, 2025, compared to $1.62 million in the prior year, indicating successful capital raising efforts.
  • The company successfully raised capital through a July 2025 private placement ($1 million gross proceeds), a September 2025 warrant inducement ($1.6 million gross proceeds), and a September 2025 PIPE transaction ($0.85 million gross proceeds).
  • An Equity Line of Credit (ELOC) agreement with White Lion Capital, LLC, provides access to up to $30 million in additional capital over 36 months, offering a potential source of future funding.
  • The company received a non-repayable government grant of $73,000 from the State of Israel in Q3 2025 related to the Iran war.
  • Cost-reduction measures contributed to a decrease in general and administrative expenses for the nine months ended September 30, 2025, compared to the prior year.
  • Financial expenses, net, decreased for both the three and nine months ended September 30, 2025, primarily due to loan repayments reducing interest expense.
  • Shareholders approved a 1-for-10 reverse stock split on November 7, 2025, as a measure to regain compliance with Nasdaq's minimum bid price requirement.
  • The Nasdaq Hearings Panel granted the company an extension until December 5, 2025, to regain compliance with the bid price requirement.

Negatives

  • Revenues for the three months ended September 30, 2025, decreased by 74.6% to $0.64 million from $2.54 million in the prior year.
  • Revenues for the nine months ended September 30, 2025, decreased by 65.6% to $2.31 million from $6.70 million in the prior year.
  • Net comprehensive loss for the three months ended September 30, 2025, increased by 287.5% to $1.98 million from $0.51 million in the prior year.
  • Net comprehensive loss for the nine months ended September 30, 2025, increased by 123.0% to $5.74 million from $2.58 million in the prior year.
  • Operating loss for the three months ended September 30, 2025, increased by 508.5% to $1.93 million from $0.32 million in the prior year.
  • Operating loss for the nine months ended September 30, 2025, increased by 159.7% to $5.51 million from $2.12 million in the prior year.
  • Net cash used in operating activities increased to $5.64 million for the nine months ended September 30, 2025, from $4.78 million in the prior year, primarily due to lower sales.
  • Cash and cash equivalents decreased to $1.45 million as of September 30, 2025, from $1.97 million at December 31, 2024.
  • The accumulated deficit increased to $49.80 million as of September 30, 2025, from $44.06 million at December 31, 2024.
  • The company's financial condition raises substantial doubt about its ability to continue as a going concern for at least one year from the issuance date of the financial statements.
  • Research and development expenses increased due to higher utilization of professional services for the GL900 product line and the strengthening of the Israeli shekel.
  • Sales and marketing expenses increased due to payroll and engaging consultants for market expansion.
  • The strengthening of the Israeli shekel against the U.S. dollar negatively impacted operating expenses and contributed to higher foreign exchange losses.
  • Inventory write-downs increased to $140,000 for the nine months ended September 30, 2025, from $39,000 in the prior year.
  • The company faces ongoing non-compliance issues with Nasdaq's minimum bid price requirement, despite an extension.

Risks

  • History of significant losses and negative cash flows from operations, with an accumulated deficit of $50 million as of September 30, 2025.
  • Inability to generate sufficient cash flow or obtain additional financing (equity or debt) on acceptable terms, or at all, which would necessitate further cost reduction plans.
  • Substantial doubt about the company's ability to continue as a going concern for at least one year from the issuance date of the financial statements.
  • The political and security situation in Israel, where the company's R&D, operations, sales (outside Americas), and administration activities are located, may harm operations, despite no material impact to date.
  • Potential for military service call-ups of employees to materially and adversely affect business, prospects, financial condition, and results of operations.
  • Commercial insurance does not cover losses from events associated with the security situation in the Middle East, and government coverage for war damages may not be maintained.
  • Risk of delisting or suspension from The Nasdaq Capital Market due to failure to regain and maintain compliance with Nasdaq's minimum shareholders' equity requirement and minimum bid price rule.
  • Delisting could negatively affect share price, impair the ability to sell or purchase shares, adversely affect the ability to raise capital, and result in loss of institutional investor interest and fewer business development opportunities.
  • The reverse stock split may not guarantee maintaining the $1.00 bid price for the required period or prevent future non-compliance.
  • The company will remain subject to a one-year discretionary Panel Monitor through October 28, 2026, with no additional cure periods for future deficiencies.
  • Potential insufficiency of disclosure controls and procedures to detect errors or acts of fraud.
  • Accuracy of estimates regarding expenses, future revenues, and capital requirements.
  • Success of competing products or technologies.
  • Ability to comply with complex and increasing governmental regulations.
  • Potential for significant disruption of global financial markets due to wars (e.g., Israel, Russia-Ukraine) reducing access to capital.
  • Concentration of credit risk with major customers (Customer A: 19%, Customer B: 14%, Customer C: 22% of trade receivables as of September 30, 2025).
  • Uncertainties concerning the fulfillment of cash flow projections, such as the ability to increase revenues and gross margin or reduce operating costs.

Future Outlook

The company expects to fund operations using existing cash, operational cash flows, and by raising additional equity and debt funds, while also improving gross margin through a better revenue mix and generating other efficiencies. However, there are no assurances that it will generate the necessary revenue or obtain sufficient financing. The company's revenues for 2025 are anticipated to be "more backend loaded." It plans to effect a 1-for-10 reverse stock split to regain Nasdaq bid price compliance by December 5, 2025. The Equity Line of Credit (ELOC) agreement provides a potential source of up to $30 million in capital over the next 36 months.

Management Comments

  • Our transition to profitable operations is dependent on generating a level of revenues adequate to support its cost and expense structure.
  • We expect to fund operations using cash on hand, through operational cash flows and raising additional equity and debt funds as well as improving its gross margin through better revenue mix and generating other efficiencies.
  • There are no assurances, however, that the Company will be able to generate the revenue necessary to support its cost and expense structure or that it will be successful in obtaining the level of financing necessary for its operations.
  • Management has evaluated the significance of these conditions and has determined that the Company does not have sufficient resources to meet its operating obligations for at least one year from the issuance date of these consolidated financial statements. These conditions raise substantial doubt as to the Companys ability to continue as a going concern.
  • Our revenues for the three months ended September 30, 2025, amounted to $0.64 million, compared to approximately $2.54 million for the three months ended September 30, 2024. The decline is associated with a software and services renewal last year for 2 years which will be up for renewal in 2027, as well as a large deal to the City of Washington D.C. last year, while 2025s revenues are more backend loaded.
  • As of the signing date, our operations and financial results have not been significantly impacted [by the Israel conflict], though, as of November 14, 2025, two of our employees have been called to reserve duty in the Israel Defense Forces from time to time, which has not been materially affecting our operation. We do not anticipate any short-term material impact on our business performance due to the ongoing conflicts in the Gaza Strip, Lebanon, Iran and the security situation in Israel.

Industry Context

Actelis Networks operates in the niche market of cyber-hardened, rapid-deployment networking solutions, particularly for wide-area IoT applications, federal, state, and local government, intelligent traffic systems, military, utility, rail, telecom, and campus sectors. Its hybrid fiber technology, which upgrades existing copper and coaxial lines to fiber-grade performance, addresses the high cost and time associated with deploying new fiber infrastructure, especially in hard-to-reach locations. The company's shift in focus from traditional telecommunication service providers to the wide-area IoT, federal, and DoD markets, and multi-dwelling units, indicates an adaptation to evolving market demands for secure and efficient connectivity solutions. The emphasis on "Triple-Shield protection" and "network-wide cyber protection software" aligns with increasing cybersecurity concerns across all sectors, particularly governmental and critical infrastructure. The ability to provide power over existing lines also addresses a significant challenge in 5G small cell and Wi-Fi base station deployments, positioning the company to capitalize on infrastructure expansion trends. However, the significant revenue decline suggests challenges in market penetration or competition, despite the strategic shift.

Comparison to Industry Standards

  • The company's significant net losses and negative Adjusted EBITDA margins (e.g., -229.67% for nine months ended Sep 30, 2025) are substantially below typical profitability standards for established technology companies.
  • The "going concern" warning indicates a severe deviation from financial stability expected of publicly traded companies, suggesting a high level of financial distress compared to industry peers.
  • The repeated non-compliance with Nasdaq listing rules (shareholders' equity and bid price) highlights a struggle to meet basic market capitalization and liquidity standards, which is atypical for healthy public companies.
  • The reliance on frequent capital raises (ATM, PIPE, warrant inducements, ELOC) to fund operations, rather than operational cash flow, is a red flag when compared to financially robust industry players who typically fund growth from earnings or strategic, less dilutive debt.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive PlanTermination of the Old 2015 Equity Incentive Plan and approval of the Actelis 2025 Equity Incentive Plan by shareholders on August 12, 2025, authorizing up to 1.8 million shares for grants.August 12, 2025Aims to provide incentives for employees, directors, and consultants, potentially aiding in talent retention and alignment with company performance.
Stock StructureShareholders approved a reverse stock split (1-for-7 to 1-for-12 range) on November 7, 2025, with the Board deciding on a 1-for-10 ratio.November 7, 2025Intended to increase the per-share price to regain compliance with Nasdaq's minimum bid price requirement, preventing delisting and maintaining market access, though it reduces the number of outstanding shares.

Legal Proceedings

  • No material legal proceedings currently pending or threatened against the company.

Stakeholder Impact

  • Shareholders face significant dilution from multiple equity raises (ATM, PIPE, warrant inducements) and potential further dilution from the ELOC. There is a risk of negative impact on share price and liquidity due to delisting concerns. The reverse stock split aims to prevent delisting but reduces the number of shares held.
  • Employees: Two employees have been called to reserve duty in the Israel Defense Forces, though this has not materially affected operations to date. Share-based compensation plans are in place to incentivize personnel.
  • Customers: The significant decline in revenues suggests potential impacts on the customer base or sales pipeline. There has been a notable shift in customer concentration, with some major customers' contributions decreasing significantly.
  • Creditors: While some loans have been repaid, a new short-term loan was taken. The 'going concern' warning indicates increased risk for creditors regarding the company's ability to meet its financial obligations.
  • Suppliers: Not explicitly mentioned, but reduced sales and cash flow could indirectly impact supplier relationships or payment terms.

Next Steps

  • Effect the 1-for-10 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement by December 5, 2025.
  • Continue efforts to generate sufficient revenue and improve gross margin to support its cost structure and achieve profitable operations.
  • Seek additional equity and debt financing as needed to fund operations.
  • Monitor and manage the impact of the political and security situation in Israel on operations.
  • File a registration statement with the SEC for the resale of shares under the ELOC Purchase Agreement and Commitment Shares.
  • Call a special meeting to obtain White Lion Shareholder Approval for the ELOC agreement within 120 days of the Commencement Date (October 1, 2025).
  • Continue to evaluate the potential impact of new accounting pronouncements (ASU 2023-09, ASU 2024-03, ASU 2025-01, ASU 2025-05, ASU 2025-07) on its consolidated financial statements.

Key Dates

DateDescription
1998Company established under Delaware laws.
July 1, 2020Received Economic Injury Disaster Loan (EIDL Loan) of $150,000.
May 12, 2022Company accepted notification of effectiveness from SEC and completed its IPO.
August 25, 2023Received Nasdaq notification of non-compliance with Minimum Shareholders Equity Requirement.
October 7, 2023Hamas terrorists initiated attacks in Southern and Central Israel, prompting Israel Defense Forces response.
December 20, 2023Issued 1,271,187 warrants with an expiration date of June 20, 2029.
January 1, 2024EIDL Loan interest payments commenced.
February 2024Partial early repayment of Migdalor Loan (2 million NIS / ~$550k).
March 24, 2024Filed Annual Report on Form 10-K for the year ended December 31, 2024.
March 27, 2024Received Nasdaq delist determination letter due to non-compliance with Equity Rule.
April 2024Additional partial early repayment of Migdalor loan (10.9 million NIS / ~$2,933k).
May 2024Signed amendment to Migdalor agreement, remaining $470k one-time interest payment to be paid in 12 monthly installments.
June 6, 2024Issued 999,670 warrants with an expiration date of December 6, 2029.
June 10, 2024Nasdaq Hearings Panel granted request for continued listing, subject to evidencing compliance with Minimum Shareholders Equity Requirement by August 27, 2025.
July 2, 2024Issued 1,999,340 warrants with an expiration date of July 2, 2026.
July 2024Repaid remaining Migdalor loan balance (1.16 million ILS / ~$0.3 million).
August 27, 2024Received formal written notice from Nasdaq confirming compliance with all applicable criteria for continued listing, including Minimum Shareholders Equity Requirement.
September 18, 2024Entered into At the Market Offering Agreement (ATM Agreement) with H.C. Wainwright & Co.
October 2024Entered into payment plan with Israel Innovation Authority (IIA) to settle outstanding royalty amount.
October 1, 2024Iran carried out drone and missile strikes against Israel.
May 12, 2025Received Nasdaq notification of non-compliance with minimum bid price rule ($1.00 per share).
June 13, 2025Israel launched a preemptive attack on Iran.
June 23, 2025Israel and Iran agreed to a ceasefire.
June 30, 2025Entered into Stock Purchase Agreement for July 2025 Private Placement.
July 2, 2025July 2025 Private Placement closed, raising $1 million gross proceeds.
August 12, 2025Shareholders approved the Actelis 2025 Equity Incentive Plan.
August 19, 2025Nasdaq issued written notice of non-compliance with Minimum Shareholders Equity Requirement as of June 30, 2025.
August 26, 2025Entered into a $400,000 short-term loan agreement with Mizrahi Tefahot Bank Ltd.
September 2, 2025Entered into warrant inducement agreement, generating $1.6 million gross proceeds.
September 3, 2025Closing of transactions contemplated by the warrant inducement letter.
September 27, 2025Entered into PIPE Purchase Agreement with White Lion for $850,000 gross proceeds.
September 27, 2025Entered into Equity Line of Credit (ELOC) agreement with White Lion Capital, LLC.
September 29, 2025White Lion Private Placement closed.
September 30, 2025End of the quarterly reporting period.
September 30, 2025Held hearing before Nasdaq Hearings Panel regarding listing compliance.
October 1, 2025Equity Line of Credit (ELOC) agreement with White Lion Capital, LLC became effective.
October 7, 2025Filed Resale Registration Statement with the SEC.
October 9, 2025Gaza Strip, Israel, Hamas, United States and other regional parties agreed to a framework for a cease-fire in Gaza.
October 9, 2025Entered into waiver agreement with Warrant Inducement Investor, granting 100,000 warrants.
October 20, 2025Amended pre-funded warrant agreement with White Lion, reducing warrant shares.
October 28, 2025Nasdaq Hearings Panel granted continued listing, with an extension through December 5, 2025, to regain bid price compliance.
November 7, 2025Special meeting of shareholders approved a reverse stock split (1-for-10 ratio decided by Board).
November 10, 2025Original deadline to regain Nasdaq minimum bid price compliance.
November 12, 2025Nasdaq letter confirming non-compliance with Bid Price Rule by Nov 10, 2025, but acknowledging Panel extension to Dec 5, 2025.
November 14, 2025Signing date of the Quarterly Report on Form 10-Q.
November 26, 2025Mizrahi Tefahot Bank Ltd. short-term loan matures.
December 5, 2025Extended deadline to regain Nasdaq minimum bid price compliance.
December 15, 2025Effective date for ASU 2023-09 (Improvements to Income Tax Disclosures).
December 15, 2025Effective date for ASU 2025-05 (Measurement of Credit Losses for Accounts Receivable and Contract Assets).
December 15, 2026Effective date for ASU 2024-03 (Disaggregation of Income Statement Expense) for annual periods.
December 15, 2026Effective date for ASU 2025-07 (Derivatives Scope Refinements) for annual periods.
December 15, 2027Effective date for ASU 2024-03 (Disaggregation of Income Statement Expense) for interim periods.
June 2050EIDL Loan matures.

Recommendation

strong sell

The company is in a precarious financial position, evidenced by substantial revenue declines, increasing net losses, and a formal "going concern" warning from management. Despite recent capital raises, these funds appear to be primarily for survival rather than driving profitable growth, and the company continues to burn cash from operations. The ongoing struggle to maintain Nasdaq listing compliance, including the need for a reverse stock split, signals severe underlying issues that are likely to lead to further share price erosion and significant investor risk. The unpredictable geopolitical risks in Israel, where a significant portion of operations are located, add another layer of uncertainty. For a seasoned investor, these factors collectively point to a high probability of continued underperformance and potential capital loss.

Keywords

Actelis Networks, ASNS, Quarterly Report, 10-Q, Financial Results, Net Loss, Revenue Decline, Going Concern, Nasdaq Compliance, Delisting Risk, Reverse Stock Split, Capital Raise, Equity Line of Credit, Warrant Inducement, Private Placement, IoT Solutions, Hybrid Fiber Networking, Cyber-hardened, Telecommunication, Israel Conflict, Financial Performance, Shareholders Equity, Operating Loss, Cash Flow, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.